These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35528735)

  • 1. Diagnostic Potential of the Serological Response to Synthetic Peptides from
    Araujo Z; de Waard JH; Camargo M; Lopez-Ramos JE; de Larrea CF; Vanegas M; Patarroyo MA
    Int J Pept Res Ther; 2022; 28(3):98. PubMed ID: 35528735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Th1 and Cytotoxic T Lymphocyte Epitopes of
    Gong W; Liang Y; Wang J; Liu Y; Xue Y; Mi J; Li P; Wang X; Wang L; Wu X
    Microbiol Spectr; 2022 Aug; 10(4):e0143822. PubMed ID: 35938824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection.
    Zhang L; Ma H; Wan S; Zhang Y; Gao M; Liu X
    Chin Med J (Engl); 2022 Jan; 135(1):63-69. PubMed ID: 34802023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Mycobacterium tuberculosis-specific antibody responses for the discrimination of active and latent tuberculosis infection.
    Wang S; Wu J; Chen J; Gao Y; Zhang S; Zhou Z; Huang H; Shao L; Jin J; Zhang Y; Zhang W
    Int J Infect Dis; 2018 May; 70():1-9. PubMed ID: 29410147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Potential of IgG and IgA Responses to
    Lee JY; Kim BJ; Koo HK; Kim J; Kim JM; Kook YH; Kim BJ
    Microorganisms; 2020 Jun; 8(7):. PubMed ID: 32629849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of HLA-DR on
    Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
    Front Immunol; 2021; 12():761209. PubMed ID: 34858413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
    Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
    BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation Phenotype of
    Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
    Front Immunol; 2021; 12():721013. PubMed ID: 34512645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific Cytokines Analysis Incorporating Latency-Associated Antigens Differentiates
    Li Y; Yang Z; Ge Q; Zhang Y; Gao M; Liu X; Zhang L
    Infect Drug Resist; 2024; 17():3385-3393. PubMed ID: 39131518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection.
    Luo Y; Tang G; Yuan X; Lin Q; Mao L; Song H; Xue Y; Wu S; Ouyang R; Hou H; Wang F; Sun Z
    Front Cell Infect Microbiol; 2021; 11():575650. PubMed ID: 34277462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection.
    Li J; Wang Y; Yan L; Zhang C; He Y; Zou J; Zhou Y; Zhong C; Zhang X
    Microbes Infect; 2022; 24(8):105002. PubMed ID: 35598729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESAT-6 and Ag85A Synthetic Peptides as Candidates for an Immunodiagnostic Test in Children with a Clinical Suspicion of Tuberculosis.
    Araujo Z; Fernández de Larrea C; López D; Isern-Kebschull J; de Waard JH; Hagel I; Camargo M; Vanegas M; Patarroyo MA
    Dis Markers; 2021; 2021():6673250. PubMed ID: 34306256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme oxygenase-1 and neopterin plasma/serum levels and their role in diagnosing active and latent TB among HIV/TB co-infected patients: a cross sectional study.
    Uwimaana E; Bagaya BS; Castelnuovo B; Kateete DP; Godwin A; Kiwanuka N; Whalen CC; Joloba ML
    BMC Infect Dis; 2021 Jul; 21(1):711. PubMed ID: 34315412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immuno-Diagnosis of Active Tuberculosis by a Combination of Cytokines/Chemokines Induced by Two Stage-Specific Mycobacterial Antigens: A Pilot Study in a Low TB Incidence Country.
    Dirix V; Collart P; Van Praet A; Hites M; Dauby N; Allard S; Racapé J; Singh M; Locht C; Mascart F; Corbière V
    Front Immunol; 2022; 13():842604. PubMed ID: 35359958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection.
    Luo Y; Tang G; Lin Q; Mao L; Xue Y; Yuan X; Ouyang R; Wu S; Yu J; Zhou Y; Liu W; Hou H; Wang F; Sun Z
    J Infect; 2020 Jul; 81(1):81-89. PubMed ID: 32360883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of
    Dreesman A; Dirix V; Smits K; Corbière V; Van Praet A; Debulpaep S; De Schutter I; Felderhof MK; Malfroot A; Singh M; Locht C; Mouchet F; Mascart F
    Front Pediatr; 2019; 7():311. PubMed ID: 31404140
    [No Abstract]   [Full Text] [Related]  

  • 18. Serological analysis reveals differential antibody responses between TB patients and latently infected individuals from the TB endemic country of Mozambique.
    Tran AC; Boariu E; García-Bengoa M; Kim MY; Vergara EJ; Mussá T; Reljic R
    Front Med (Lausanne); 2023; 10():1286785. PubMed ID: 37877025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of diagnostic algorithm using machine learning for distinguishing between active tuberculosis and latent tuberculosis infection.
    Luo Y; Xue Y; Liu W; Song H; Huang Y; Tang G; Wang F; Wang Q; Cai Y; Sun Z
    BMC Infect Dis; 2022 Dec; 22(1):965. PubMed ID: 36581808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study.
    Li H; Ren W; Liang Q; Zhang X; Li Q; Shang Y; Ma L; Li S; Pang Y
    QJM; 2023 Dec; 116(12):1002-1009. PubMed ID: 37740371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.